4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-24-019373
Chief Financial Officer sold 248 shares at $4.98 ($1,235)
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-18 | Sale : show line 1 in the form | −248 | $4.98 | $1,235 | 154,330 | D |
| Open-market sales · 248 sh · avg $4.98 · $1,235 | ||||||
Loading xslF345X05/form4.xml…